Schorno Dean Linsider trades
In SEC Form 4 filings, Schorno Dean L is listed as EVP & Chief Financial Officer of Rigel Pharmaceuticals Inc (RIGL). Schorno Dean L reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RIGLRigel Pharmaceuticals Inc | EVP & Chief Financial Officer | 9 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M | 694 | $12.70 | $8,814 | 79,056 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M | 620 | $18.70 | $11,594 | 79,676 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M | 2,000 | $24.20 | $48,400 | 81,676 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M | 1,286 | $24.20 | $31,121 | 82,962 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M · derivative | 694 | $12.70 | $8,814 | 12,824 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M · derivative | 620 | $18.70 | $11,594 | 9,012 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M · derivative | 2,000 | $24.20 | $48,400 | 7,999 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 2 | Sep 3 | M · derivative | 1,286 | $24.20 | $31,121 | 15,867 | No | Form 4 |
| RIGLRigel Pharmaceuticals Inc | Sep 1 | Sep 3 | F | 928 | $47.50 | $44,080 | 78,362 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.